×

Kraig Biocraft Laboratories' Spider Silk Production Efficiency Doubles

Kraig Bancraft Logo

LANSING, Mich., March 24, 2014 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the leading developer of advanced spider silk based fibers, announced today that its genetically engineered spider silk, Monster Silk™, production program has more than doubled in productivity.

During the pilot production program, the yield rate of viable silk cocoons was approximately 30%. At those rates, the cost structure warranted the conversion of the pilot test program to a much larger scale.

The latest reports from the current production ramp up point to a dramatic and unexpected increase in yield to 70%; more than double the output efficiency shown during the pilot phase.

The initial assessment from the Company's scientific team is that the Monster Silkworms™ are acclimating to the production environment.

"This dramatic boost in productivity was a surprise to us. Our plan was to methodically increase productivity rates over the next 18 months. Our team had drawn up plans that included selective breeding and cross breeding to achieve those goals. To see such a remarkable gain in so short a time was beyond our expectations. The obvious benefits, should these rates continue, would include reduced production costs and reduced ramp up time," said Company Founder and CEO, Kim K. Thompson.

"With this doubling in efficiency, we need to focus on emplacing the necessary infrastructure to support the increased productivity. As far as challenges go, these are good problems to have. We have already taken action to beef up our production infrastructure to support these larger numbers. The improvement in performance is dramatic; but, with such significant advancements I am cautious until I see that results are consistent over the next few months," Thompson concluded.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

CONTACT: Ben Hansel, Hansel Capital, LLC. (720) 288-8495 ir@KraigLabs.com

Source:Kraig Biocraft Laboratories, Inc